ÐÂÎÅ×ÊѶ
ÁÙ½ÊÐÈËÃñÒ½Ôº
¼ìÑé¿Æ ÍõºéÖ¥ Ëβ¨
¦Â2-΢Çòµ°°×(¦Â2-MG)ÊÇÒ»ÖÖ¶àëÄ[1]£¬ÊÇÓÐÃûµÄ¹Ü¼Ò»ùÒò£¬µÍÏà¶Ô·Ö×ÓÖÊÁ¿(118000)µÄ·ÇÌÇ»ù»¯µ°°×¡£´ó¶àÊýµÄ¦Â2-MGͨ³£±»ÉöÔàÇå³ý£¬Í¨¹ýÉöСÇòÂ˹ýºóÔÚÉöС¹Ü·Ö½â£¬ÆäËûµÄÆÆ»µºÍÏû³ý¿ÉÒÔºöÂÔ²»¼Æ¡£¦Â2-MGÓɽü¶ËС¹ÜÖØÎüÊÕ[2]£¬Òò´ËÆäѪ½¬Å¨¶ÈÓëÉö¹¦ÄÜÃÜÇÐÏà¹Ø£¬¿É×÷ΪÉöСÇòÂ˹ýÂʵÄÒ»¸öÖ¸±ê¡£
¦Â2-MG¹ã·º´æÔÚÓÚѪÇå¡¢ÄÔ¼¹Òº¡¢ÍÙÒº¡¢³õÈé¡¢ÑòË®¡¢¾«Òº¼°ÄòÒºµÈÌåÒºÖС£ÆäÉúÀí×÷ÓÃÖ÷ҪΪÎȶ¨HLA¢ñÀ࿹Եıí´ï¡£
ѪҺÖеĦÂ2-MG³Ê×ÔÓÉ̬£¬²»ÓëѪ½¬µ°°×½áºÏ£¬ÓÖÒòÆä·Ö×ÓÁ¿Ð¡£¬Òò´ËѪҺÖеĦÂ2-MG¿Éͨ¹ýÉöСÇò×ÔÓÉÂ˳ö£¬¶øÆäºóÔ¼99. 9%µÄ¦Â2-MGÓɽü¶ËÉöС¹ÜÒÔ°ûÒûµÄ·½Ê½ÉãÈ¡²¢½µ½âΪ°±»ùËᣬËùÒÔ½öÓÐ΢Á¿µÄ¦Â2-MG×ÔÄòÖÐÅųö[3]¡£ÑªÓëÄòÒºÖоù¿É¼ì²â³ö¦Â2-MG£¬ÄǦÂ2-MG¾¿¾¹ÊǸüì²âѪҺ±ê±¾»¹ÊÇÄòÒº±ê±¾£¿
Ѫ¦Â2-MGÊÇ·´Ó³ÉöСÇòÂ˹ý¹¦ÄܵÄÁéÃôÖ¸±ê
Ѫ¦Â2-MGÊÇ·´Ó³ÉöСÇòÂ˹ý¹¦ÄܵÄÁ¼ºÃÖ¸±ê£¬ÇÒÓ뻼ÕßÄêÁä¡¢ÐÔ±ð¡¢Éö¹¦ÄÜ״̬Î޹أÛ4£Ý¡£
¦Â2-MGµÄС·Ö×ÓÌØÐÔÔÊÐíÆä×ÔÓÉ´©¹ýÉöСÇòĤ£¬ÉöСÇò¹¦ÄÜÎÉÂһᵼÖÂѪÖЦÂ2-MGÉÏÉý£¬Òò´ËѪҺ¦Â2-MGÊÇ·´Ó³ÉöСÇòÂ˹ý¹¦ÄܵÄÁéÃôÖ¸±ê£¬¸÷ÖÖÔ·¢ÐÔ»ò¼Ì·¢ÐÔÉöСÇò²¡±äÈçÀÛ¼°ÉöСÇòÂ˹ý¹¦ÄÜ£¬¾ù¿ÉÖÂѪ¦Â2-MGÉý¸ß¡£¶ÔÉöСÇòÂ˹ý¹¦ÄÜ£¬ÆäÃô¸Ð¶ÈÏÔÖø¸ßÓÚѪ¼¡ôû²â¶¨£¬¶ÔѪ¼¡ôû²â¶¨´¦ÓÚÃ¤Çø¶øÉöСÇòÂ˹ý¹¦ÄÜÒÑÊÜË𺦵ϼÕߣ¬ÑªÒºBMG²â¶¨ÓÐÀûÓÚÔçÆÚ·¢ÏÖÉöСÇòÂ˹ý¹¦ÄÜÒì³£¡£
Òò´Ë£¬ÑªÒº¦Â2-MGŨ¶È¿ÉÓÃ×÷¸ßѪѹ²¡ºÍÌÇÄò²¡»¼ÕßÉö¹¦ÄÜÊÜËðµÄÔçÆÚÕï¶ÏÃô¸ÐÖ¸±ê¡£
Ѫ¦Â2-MGÔÚ͸ÎöÏà¹ØÐÔµí·ÛÑù±äÖеÄ×÷ÓÃ
ѪÇå¦Â2-΢Çòµ°°×(¦Â2-MG)ÊÇ·´Ó³»¼ÕßÌåÖзÖ×Ó¶¾ËØË®Æ½¼°ÆÀ¼Û͸ÎöģʽµÄÖзÖ×ÓÈÜÖÊÇå³ýÄÜÁ¦µÄ±êÖ¾Îï[5]¡£
¦Â2-MGÊÇÓ°Ïì³ÖÐøÐÔ͸Îö»¼ÕßÔ¶ÆÚÔ¤ºóµÄÖØÒªÖдó·Ö×Ó¶¾ËØ£¬³¤ÆÚµÄÐî»ý»áµ¼ÖÂ͸ÎöÏà¹Øµí·ÛÑù±ä(DRA)[6]£¬ÇÒËüÔÚѪÇåÖк¬Á¿Ë®Æ½²»ÊÜʳÎï´úлӰÏ죬ĿǰÁÙ´²Òѽ«¦Â2-MG×÷Ϊ͸ÎöÊÇ·ñ³ä·ÖµÄÒ»¸ö¹Ø¼üÐÔÖ¸±ê¡£
ѪҺ¦Â2-MGµÄŨ¶ÈÒ²ÊÇijЩѪҺ¶ñÐÔÖ×ÁöµÄ±êÖ¾Îï
Ö×Áöϸ°û±¾ÉíºÏ³ÉºÍ·ÖÃÚ¦Â2-MG¼ÓËÙ³¬¹ýÁËÕý³£Ï¸°û¶øÖÂÆäº¬Á¿Ôö¸ß£»Ö×Áöϸ°ûÒì³£ÔöÉú´óÁ¿µÄϸ°ûÆÆ»µ¶øÖ¦Â2-MGÊÍ·ÅÁ¿Ôö¼Ó£»Ö×Áöϸ°ûÖ±½Ó½þÈóÉö×éÖ¯²úÉúÃâÒßÔÐÔÎïÖʶøÖÂÉöËðÉËʹ¦Â2-MGµÄÎüÊÕ¡¢½µ½â ¼õÉٵȡ£
Ѫ¦Â2-MGÊÇÒÔÁܰÍϸ°ûÔöÖ³ÐÔ¼²²¡µÄÖ÷Òª±êÖ¾ÎÈç¶à·¢ÐÔ¹ÇËèÁö¡¢ÂýÐÔÁܰÍÐÔ°×Ѫ²¡µÈ£¬Ñª¦Â2-MGŨ¶ÈÃ÷ÏÔÔö¼Ó¡£
¦Â2-MGÊÇ·´Ó³½ü¶ËÉöС¹ÜÖØÎüÊÕ¹¦ÄܵÄÁ¼ºÃÖ¸±ê
ÔÄòÖÐԼΪ99. 9%µÄ¦Â2-MG±»½ü¶ËÉöС¹ÜÖ÷¶¯ÖØÎüÊÕ£¬ÇÒ½ü¶ËÉöС¹ÜÊÇÈËÌåÄÚ´¦Àí¦Â2-MGµÄΨһ³¡Ëù¡£Òò´ËÎÞÂÛÊÇÔ·¢ÐÔÉö¼²²¡£¬»¹ÊÇÆäËüµÄ¿ÉÒÔÒýÆð¼Ì·¢ÐÔÉöËðÉ˵ÄÇé¿ö¶¼¿ÉÔì³ÉÉöС¹ÜÖØÎüÊÕ¹¦ÄÜËðÉ˵쬶¼¿ÉÒýÆðÄò¦Â2-MGÉý¸ß¡£
¦Â2-MGÊÇÕï¶ÏÉöÔçÆÚËðÉ˵ÄÁéÃôÖ¸±ê£¬ÓÈÆä¶Ô½ü¶ËÉöС¹ÜµÄ¹¦Äܼà²â¾ßÓÐÖØÒªÒâÒå¡£
ѪºÍÄò¦Â2-MGͬ²â£¬¸üÓÐÖúÓÚÉöÔ༲²¡É¸²é
Ѫ¦Â2-MGÉý¸ß¶øÄò¦Â2-MGÕý³££¬Ö÷ÒªÔÒò¿ÉÄÜÊÇÉöСÇòÂ˹ý¹¦ÄÜϽµ£¬³£¼ûÓÚ¼±¡¢ÂýÐÔÉöÑ×£¬Éö¹¦ÄÜË¥½ßµÈ¡£
Ѫ¦Â2-MGÕý³£¶øÄò¦Â2-MGÉý¸ß£¬Ö÷ÒªÔÒòÊÇÉöС¹ÜÖØÎüÊÕ¹¦ÄÜÃ÷ÏÔÊÜË𣬼ûÓÚÏÈÌìÐÔ½üÇúС¹Ü¹¦ÄÜȱÏÝ£¬·¶¿ÆÄá×ÛºÏÕ÷£¬ÂýÐÔïÓÖж¾£¬Wilson²¡£¬ÉöÒÆÖ²ÅųⷴӦµÈ¡£
Ѫ¡¢Äò¦Â2-MG¾ùÉý¸ß£¬¿ÉÄÜÊÇÓÉÓÚÌåÄÚijЩ²¿Î»²úÉú¹ý¶à¦Â2-MG£¬»òÉöСÇòºÍÉöС¹Ü¶¼Êܵ½ËðÉ˵ÄÉö²¡ÒýÆð£¬³£¼ûÓÚ¶ñÐÔÖ×Áö(ÈçÔ·¢ÐԸΰ©¡¢·Î°©¡¢¹ÇËèÁöµÈ)£¬×ÔÉíÃâÒßÐÔ¼²²¡(ÈçϵͳÐÔºì°ßÀÇ´¯¡¢ÈÜѪÐÔÆ¶Ñª)£¬ÂýÐÔ¸ÎÑ×£¬ÌÇÄò²¡Éö²¡µÈ¡£ÀÏÄêÈËÒ²¿É¼ûѪ¡¢Äò¦Â2-MGÉý¸ß¡£
½áÂÛ£º
ÉöÔ༲²¡ÔÚʹÓøßÁéÃô¶È¡¢¸ßÌØÒìÐԵļì²âÏîÄ¿¦Â2-MGµÄͬʱ£¬¸üÓ¦¸ÃѪ¡¢Äòͬ²â£¬Ìá¸ßÉöÔ༲²¡¼ì³öÂÊ£¬×öµ½ÉöÔ༲²¡Ôçɸ¡¢ÔçÕï¡¢ÔçÖΡ£
²Î¿¼ÎÄÏ×£º
[1]ÕÅäìÒÁ,Øáï£,×ÞÔÆÔö.¦Â2-΢Çòµ°°×µÄÑо¿½øÕ¹[J].ÖйúÁÙ´²Ò©ÀíѧÓëÖÎÁÆÑ§,2022 ,390-396.
[2]Aksun SA, Ozmen D , OzmenB , et al . Beta2-microglobulin and cystatin C in type 2 diabetes: assessment of diabetic nephropathy[J].Exp Clin Endocrinol Diabetes , 2004 , 112(4):195 200.
[3]×Þ´æ¹ú,ÉÐç÷,ÕÅÎÄÀö.Ѫ¡¢Äò2-΢Çòµ°°×ˮƽÓëÉöÔàËðÉË[J].ÎÀÉúÑо¿,2011,812-814.
[4]JOVANOVIC D , KRSTIVOJEVICP , OBRADOVICI, et al . Serum cystatin C and ¦Â2 -microglobulin as markers of glomerular filtration rate[J] . Renal Failure , 2003 , 25(1) : 123-133.
[5]SIRICH TL, PLUMMER NS, GARDNER CD, et al. Effect of increasing dietary fiber on plasma levels of colon-derived Ssolutes in hemodialysis patients [J]. Clin J Am Soc Nephrol, 2014, 9(9): 1603-1610.
[6]²è´ºÀö,À¾ê,³Â¹úæ,µÈ.͸Îö»¼Õß΢Ñ×֢״̬ÓëѪ֬´úл¼°¸ÆÁ×´úлµÄÏà¹ØÐÔ[J].À¥Ã÷Ò½¿Æ´óѧѧ±¨, 2017, 38(1): 41-45.
ÉùÃ÷£º±¾ÍøÕ¾Ëù·¢±íÄÚÈÝ×¢Ã÷À´Ô´µÄ£¬°æÈ¨¹éÔ³ö´¦ËùÓУ¬Óë±¾ÍøÕ¾Á¢³¡Î޹ء£ÈçÓÐÇÖȨÇëÁôÑÔÁªÏµÐ¡±àɾ³ý¡£